These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18167219)

  • 21. Alginate-whey protein granular microspheres as oral delivery vehicles for bioactive compounds.
    Chen L; Subirade M
    Biomaterials; 2006 Sep; 27(26):4646-54. PubMed ID: 16714058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the biodegradable polymer chitosan as a vehicle for applying drugs to the inner ear.
    Saber A; Strand SP; Ulfendahl M
    Eur J Pharm Sci; 2010 Jan; 39(1-3):110-5. PubMed ID: 19931387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of polysaccharide gel-coated pellets for oral administration. 2. Calcium alginate.
    Sriamornsak P; Kennedy RA
    Eur J Pharm Sci; 2006 Oct; 29(2):139-47. PubMed ID: 16919918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease.
    Oshi MA; Naeem M; Bae J; Kim J; Lee J; Hasan N; Kim W; Im E; Jung Y; Yoo JW
    Carbohydr Polym; 2018 Oct; 198():434-442. PubMed ID: 30093020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Middle ear application of a sodium hyaluronate gel loaded with neomycin in a Guinea pig model.
    Saber A; Laurell G; Bramer T; Edsman K; Engmér C; Ulfendahl M
    Ear Hear; 2009 Feb; 30(1):81-9. PubMed ID: 19125030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyelectrolyte-coated alginate microspheres as drug delivery carriers for dexamethasone release.
    Jayant RD; McShane MJ; Srivastava R
    Drug Deliv; 2009 Aug; 16(6):331-40. PubMed ID: 19606947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individual differences in the permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear.
    Yoshioka M; Naganawa S; Sone M; Nakata S; Teranishi M; Nakashima T
    Otol Neurotol; 2009 Aug; 30(5):645-8. PubMed ID: 19415042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro release and characterization of chitosan films as dexamethasone carrier.
    Rodrigues LB; Leite HF; Yoshida MI; Saliba JB; Cunha AS; Faraco AA
    Int J Pharm; 2009 Feb; 368(1-2):1-6. PubMed ID: 18955123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme.
    Rawat M; Singh D; Saraf S; Saraf S
    Drug Dev Ind Pharm; 2008 Feb; 34(2):181-8. PubMed ID: 18302037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dexamethasone pharmacokinetics in Guinea pig inner ear perilymph.
    Liu HJ; Dong MM; Chi FL
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(2):93-8. PubMed ID: 16446554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled release from fibers of polyelectrolyte complexes.
    Liao IC; Wan AC; Yim EK; Leong KW
    J Control Release; 2005 May; 104(2):347-58. PubMed ID: 15907585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct round window application of gentamicin with varying delivery vehicles: a comparison of ototoxicity.
    Sheppard WM; Wanamaker HH; Pack A; Yamamoto S; Slepecky N
    Otolaryngol Head Neck Surg; 2004 Dec; 131(6):890-6. PubMed ID: 15577786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dexamethasone pharmacokinetics in perilymph of guinea pig after different topical administrations].
    Hou D; Wu H; Yang J; Zhang P; Zhang S; Chen J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):307-10. PubMed ID: 16001898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders.
    Piu F; Wang X; Fernandez R; Dellamary L; Harrop A; Ye Q; Sweet J; Tapp R; Dolan DF; Altschuler RA; Lichter J; LeBel C
    Otol Neurotol; 2011 Jan; 32(1):171-9. PubMed ID: 21099726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor.
    Ho YC; Mi FL; Sung HW; Kuo PL
    Int J Pharm; 2009 Jul; 376(1-2):69-75. PubMed ID: 19450670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Floating dosage forms to prolong gastro-retention--the characterisation of calcium alginate beads.
    Stops F; Fell JT; Collett JH; Martini LG
    Int J Pharm; 2008 Feb; 350(1-2):301-11. PubMed ID: 17964096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration.
    Hahn H; Kammerer B; DiMauro A; Salt AN; Plontke SK
    Hear Res; 2006 Feb; 212(1-2):236-44. PubMed ID: 16442251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel pulsed drug-delivery system: polyelectrolyte layer-by-layer coating of chitosan-alginate microgels.
    Zhou G; Lu Y; Zhang H; Chen Y; Yu Y; Gao J; Sun D; Zhang G; Zou H; Zhong Y
    Int J Nanomedicine; 2013; 8():877-87. PubMed ID: 23486565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterizing short-term release and neovascularization potential of multi-protein growth supplement delivered via alginate hollow fiber devices.
    Tilakaratne HK; Hunter SK; Andracki ME; Benda JA; Rodgers VG
    Biomaterials; 2007 Jan; 28(1):89-98. PubMed ID: 16952396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium alginate beads embedded in silk fibroin as 3D dual drug releasing scaffolds.
    Mandal BB; Kundu SC
    Biomaterials; 2009 Oct; 30(28):5170-7. PubMed ID: 19552952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.